Dr Jorg Taubel, CEO of Richmond Pharmacology commented saying:
“The opening of our new research facility is a sign of our continued commitment to working alongside the leading research hospitals and universities in the UK to deliver cutting-edge clinical research across vital disease areas.
“Richmond are committed to making a significant and meaningful contribution to the health of the UK’s population and ensuring a sustainable future for the NHS through supporting the development of life changing and innovative medicines”
I am very pleased with the Project Management of both studies undertaken on behalf of (blank) and any future studies we have to outsource will automatically be contracted to you.
- Anonymous
Many thanks for your time today, most impressed with the quality of the follow up to our enquiry.
- Anonymous
Please know that it has been an absolute pleasure collaborating with you and that I am most appreciative of the key contributions RPL has made to this project thus far. I hope I have the opportunity to work with RPL again in the very near future.
- Anonymous
Richmond Pharmacology CEO, Dr Jorg Taubel, Franklin Gordon, Resuscitation Simulation & Clinical Skills Practitioner
Read more ›Significant work has been undertaken to push forward the launch of a new apprentice scheme aimed at raising the
Read more ›Richmond Pharmacology’s Research Director Dr Radivoj Arezina has written a piece for the July edition of GMP Review
Read more ›The Changing Landscape of Early Medicines Development: Be Prepared! Lyon Conference, France, 15-17 May
View event ›
+44 (0) 20 7042 5800
